NEOM McLaren has become the latest FIA Formula E team to reveal its livery for the upcoming 11th Season of the all-electric championship. Sticking to tradition, the team has opted for a papaya colour ...

Learn More ResMed Inc (ASX: RMD) shares have extended gains this month, closing at fresh 52-week highs of $39.07 apiece on Monday. They have since retreated to $37.72 at the time of writing after ...

Analysts reckon Ozempic-style obesity drugs won’t affect Resmed’s fortunes – at least in the short term Dimerix is confident it can use another surrogate endpoint in its pivotal kidney disease trial ...

Ulefone has recently launched Ulefone S11 in March 2019. The body of Ulefone S11 is made out of Plastic. The smartphone comes in three different colors Black, Blue, and Twilight. The phone handles ...

ResMed Inc (NYSE:RMD) reports a robust 11% increase in net revenue year-over-year. Significant growth in Sleep and Breathing Health segment, showcasing an 11% rise in sales. Strong gross margin ...

as we get full AirSense 11 capabilities, everyone who's at that five-year point gets the chance to say, ‘Yes, I want the latest and greatest therapy.’” ‘It will be a benign pricing environment’ ...

Hello, and welcome to the Q1 Fiscal Year 2025 ResMed Earnings Conference Call ... driven by strong market performance from both the AirSense 10 and the AirSense 11 platforms.

ResMed Inc (NYSE:RMD) is expanding the availability of its AirSense 11 platform worldwide, which is expected to drive ongoing momentum. The masks and accessories segment saw an 11% year-over-year ...

ResMed stands to benefit from Philips’ significant product recall and the launch of its new flagship product, AirSense 11. Market share gains from Philips’ product recall may be limited as ...

For the three months ended 30 September, ResMed reported an 11% increase in revenue to US$1,224.5 million. This was largely in line with consensus estimates for the period. Management advised that ...

Oct 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the ...

ResMed specializes in designing and manufacturing devices and software solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its commitment to ...